vs
Side-by-side financial comparison of KAMADA LTD (KMDA) and Orchid Island Capital, Inc. (ORC). Click either name above to swap in a different company.
KAMADA LTD is the larger business by last-quarter revenue ($47.0M vs $38.5M, roughly 1.2× Orchid Island Capital, Inc.). Orchid Island Capital, Inc. runs the higher net margin — 268.7% vs 11.3%, a 257.4% gap on every dollar of revenue. On growth, Orchid Island Capital, Inc. posted the faster year-over-year revenue change (372.6% vs 12.6%). Over the past eight quarters, Orchid Island Capital, Inc.'s revenue compounded faster (301.6% CAGR vs 12.0%).
Kamada Ltd. is a global biopharmaceutical company specializing in the research, manufacturing, and commercialization of specialty pharmaceuticals derived from human plasma.
Orchid Island Capital, Inc. is a U.S.-based specialty finance company operating as a real estate investment trust. It primarily invests in residential mortgage-backed securities, including agency and non-agency products, targeting consistent risk-adjusted returns for its investors across U.S. fixed income markets.
KMDA vs ORC — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.0M | $38.5M |
| Net Profit | $5.3M | $103.4M |
| Gross Margin | 42.0% | — |
| Operating Margin | 16.6% | — |
| Net Margin | 11.3% | 268.7% |
| Revenue YoY | 12.6% | 372.6% |
| Net Profit YoY | 37.1% | 1764.9% |
| EPS (diluted) | $0.09 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $38.5M | ||
| Q3 25 | $47.0M | $26.9M | ||
| Q2 25 | $44.8M | $23.2M | ||
| Q1 25 | $44.0M | $19.7M | ||
| Q3 24 | $41.7M | $340.0K | ||
| Q2 24 | $42.5M | $-697.0K | ||
| Q1 24 | $37.7M | $-2.5M | ||
| Q3 23 | $37.9M | — |
| Q4 25 | — | $103.4M | ||
| Q3 25 | $5.3M | $72.1M | ||
| Q2 25 | $7.4M | $-33.6M | ||
| Q1 25 | $4.0M | $17.1M | ||
| Q3 24 | $3.9M | $17.3M | ||
| Q2 24 | $4.4M | $-5.0M | ||
| Q1 24 | $2.4M | $19.8M | ||
| Q3 23 | $3.2M | — |
| Q4 25 | — | — | ||
| Q3 25 | 42.0% | — | ||
| Q2 25 | 42.3% | — | ||
| Q1 25 | 47.1% | — | ||
| Q3 24 | 41.3% | — | ||
| Q2 24 | 44.6% | — | ||
| Q1 24 | 44.4% | — | ||
| Q3 23 | 39.0% | — |
| Q4 25 | — | — | ||
| Q3 25 | 16.6% | — | ||
| Q2 25 | 15.8% | — | ||
| Q1 25 | 17.7% | — | ||
| Q3 24 | 12.7% | — | ||
| Q2 24 | 13.3% | — | ||
| Q1 24 | 10.7% | — | ||
| Q3 23 | 11.5% | — |
| Q4 25 | — | 268.7% | ||
| Q3 25 | 11.3% | 267.8% | ||
| Q2 25 | 16.5% | -145.0% | ||
| Q1 25 | 9.0% | 86.9% | ||
| Q3 24 | 9.3% | 5094.1% | ||
| Q2 24 | 10.4% | 714.3% | ||
| Q1 24 | 6.3% | -794.2% | ||
| Q3 23 | 8.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | $0.09 | — | ||
| Q2 25 | $0.13 | — | ||
| Q1 25 | $0.07 | — | ||
| Q3 24 | $0.07 | — | ||
| Q2 24 | $0.08 | — | ||
| Q1 24 | $0.04 | — | ||
| Q3 23 | $0.06 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.0M | $665.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $265.2M | $1.4B |
| Total Assets | $377.2M | $11.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $665.9M | ||
| Q3 25 | $72.0M | $583.9M | ||
| Q2 25 | $66.0M | $440.8M | ||
| Q1 25 | $76.3M | $396.4M | ||
| Q3 24 | $72.0M | $322.1M | ||
| Q2 24 | $56.5M | $241.0M | ||
| Q1 24 | $48.2M | $190.4M | ||
| Q3 23 | $52.6M | — |
| Q4 25 | — | $1.4B | ||
| Q3 25 | $265.2M | $1.1B | ||
| Q2 25 | $260.0M | $912.0M | ||
| Q1 25 | $252.0M | $855.9M | ||
| Q3 24 | $255.3M | $656.0M | ||
| Q2 24 | $251.2M | $555.9M | ||
| Q1 24 | $251.2M | $481.6M | ||
| Q3 23 | $238.4M | — |
| Q4 25 | — | $11.7B | ||
| Q3 25 | $377.2M | $9.1B | ||
| Q2 25 | $368.2M | $7.6B | ||
| Q1 25 | $375.1M | $7.3B | ||
| Q3 24 | $351.2M | $5.9B | ||
| Q2 24 | $351.0M | $4.9B | ||
| Q1 24 | $343.2M | $4.2B | ||
| Q3 23 | $337.1M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $10.4M | $120.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 1.97× | 1.16× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $120.4M | ||
| Q3 25 | $10.4M | $28.0M | ||
| Q2 25 | $8.0M | $18.4M | ||
| Q1 25 | $-513.0K | $25.8M | ||
| Q3 24 | $22.2M | $-14.8M | ||
| Q2 24 | $14.0M | $19.3M | ||
| Q1 24 | $1.0M | $45.0M | ||
| Q3 23 | $921.0K | — |
| Q4 25 | — | 1.16× | ||
| Q3 25 | 1.97× | 0.39× | ||
| Q2 25 | 1.09× | — | ||
| Q1 25 | -0.13× | 1.51× | ||
| Q3 24 | 5.75× | -0.86× | ||
| Q2 24 | 3.15× | — | ||
| Q1 24 | 0.43× | 2.28× | ||
| Q3 23 | 0.29× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
